JP2010528590A5 - - Google Patents

Download PDF

Info

Publication number
JP2010528590A5
JP2010528590A5 JP2010509537A JP2010509537A JP2010528590A5 JP 2010528590 A5 JP2010528590 A5 JP 2010528590A5 JP 2010509537 A JP2010509537 A JP 2010509537A JP 2010509537 A JP2010509537 A JP 2010509537A JP 2010528590 A5 JP2010528590 A5 JP 2010528590A5
Authority
JP
Japan
Prior art keywords
snps
lupus
subject
group
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010509537A
Other languages
English (en)
Japanese (ja)
Other versions
JP5728226B2 (ja
JP2010528590A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/064430 external-priority patent/WO2008144761A2/en
Publication of JP2010528590A publication Critical patent/JP2010528590A/ja
Publication of JP2010528590A5 publication Critical patent/JP2010528590A5/ja
Application granted granted Critical
Publication of JP5728226B2 publication Critical patent/JP5728226B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010509537A 2007-05-21 2008-05-21 狼瘡の同定と治療のための方法及び組成物 Active JP5728226B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US93915607P 2007-05-21 2007-05-21
US60/939,156 2007-05-21
US1328307P 2007-12-12 2007-12-12
US61/013,283 2007-12-12
PCT/US2008/064430 WO2008144761A2 (en) 2007-05-21 2008-05-21 Methods and compositions for identifying and treating lupus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015079282A Division JP6080059B2 (ja) 2007-05-21 2015-04-08 狼瘡の同定と治療のための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2010528590A JP2010528590A (ja) 2010-08-26
JP2010528590A5 true JP2010528590A5 (cg-RX-API-DMAC7.html) 2011-07-07
JP5728226B2 JP5728226B2 (ja) 2015-06-03

Family

ID=40122294

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2010509537A Active JP5728226B2 (ja) 2007-05-21 2008-05-21 狼瘡の同定と治療のための方法及び組成物
JP2015079282A Active JP6080059B2 (ja) 2007-05-21 2015-04-08 狼瘡の同定と治療のための方法及び組成物
JP2016178303A Pending JP2017035088A (ja) 2007-05-21 2016-09-13 狼瘡の同定と治療のための方法及び組成物
JP2018050492A Pending JP2018126146A (ja) 2007-05-21 2018-03-19 狼瘡の同定と治療のための方法及び組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015079282A Active JP6080059B2 (ja) 2007-05-21 2015-04-08 狼瘡の同定と治療のための方法及び組成物
JP2016178303A Pending JP2017035088A (ja) 2007-05-21 2016-09-13 狼瘡の同定と治療のための方法及び組成物
JP2018050492A Pending JP2018126146A (ja) 2007-05-21 2018-03-19 狼瘡の同定と治療のための方法及び組成物

Country Status (14)

Country Link
US (1) US20110046094A1 (cg-RX-API-DMAC7.html)
EP (3) EP2158335A2 (cg-RX-API-DMAC7.html)
JP (4) JP5728226B2 (cg-RX-API-DMAC7.html)
KR (4) KR20190015629A (cg-RX-API-DMAC7.html)
CN (3) CN104593488B (cg-RX-API-DMAC7.html)
AU (1) AU2008254582A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0811930B8 (cg-RX-API-DMAC7.html)
CA (1) CA2690608C (cg-RX-API-DMAC7.html)
ES (1) ES2661249T3 (cg-RX-API-DMAC7.html)
HK (1) HK1255086A1 (cg-RX-API-DMAC7.html)
IL (1) IL201949A0 (cg-RX-API-DMAC7.html)
MX (3) MX378733B (cg-RX-API-DMAC7.html)
RU (1) RU2009147281A (cg-RX-API-DMAC7.html)
WO (1) WO2008144761A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2661249T3 (es) * 2007-05-21 2018-03-28 Genentech, Inc. Métodos y composiciones para identificar y tratar el lupus
US20100099101A1 (en) * 2008-09-26 2010-04-22 Genentech, Inc. Methods for treating, diagnosing, and monitoring lupus
US20100105061A1 (en) * 2008-10-29 2010-04-29 University Of Southern California Autoimmune genes identified in systemic lupus erythematosus (sle)
EP2403959A1 (en) * 2009-03-03 2012-01-11 Merck Serono S.A. Bank1 related snps and sle and/or ms susceptibility
CN113025703A (zh) * 2009-10-07 2021-06-25 弗·哈夫曼-拉罗切有限公司 用于治疗、诊断和监控狼疮的方法
MX2012010116A (es) * 2010-03-01 2013-02-26 Alexion Pharma Inc Metodos y composiciones para el tratamiento de la enfermedad de degos.
US20140112913A1 (en) * 2011-02-10 2014-04-24 Genqual Corporation Methods of prognosing and administering treatment for inflammatory disorders
US20130317006A1 (en) 2012-05-24 2013-11-28 Amy Yasko Use of polymorphisms for identifying individuals at risk of developing autism
WO2015081052A1 (en) 2013-11-27 2015-06-04 Yasko Amy Use of polymorphisms for identifying individuals at risk of developing autism
AU2016281766B2 (en) * 2015-06-24 2019-05-09 Oxford BioDynamics PLC Epigenetic chromosome interactions
CN110459312B (zh) * 2018-05-07 2024-01-12 深圳华大生命科学研究院 类风湿性关节炎易感位点及其应用
WO2021127589A1 (en) * 2019-12-18 2021-06-24 The Children's Hospital Of Philadelphia Novel druggable targets for the treatment of inflammatory diseases such as systemic lupus erythematosus (sle) and methods for diagnosis and treatment using the same
KR20240021336A (ko) 2022-08-09 2024-02-19 심재홍 수액 채취장치의 냉각기 구조

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4683203A (en) 1984-04-14 1987-07-28 Redco N.V. Immobilized enzymes, processes for preparing same, and use thereof
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
GB9114948D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
ATE390933T1 (de) 1995-04-27 2008-04-15 Amgen Fremont Inc Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
CA2255774C (en) * 1996-05-29 2008-03-18 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
AU2001265121A1 (en) 2000-05-30 2001-12-11 Applera Corporation Methods for detecting target nucleic acids using coupled ligation and amplification
US6900016B1 (en) 2000-09-08 2005-05-31 Applera Corporation Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof
NZ525336A (en) * 2000-10-20 2006-03-31 Expression Diagnostics Inc Leukocyte expression profiling
US7205106B1 (en) 2001-07-20 2007-04-17 Roche Molecular Systems, Inc. Association of polymorphisms in IL4-related genes with autoimmune disease
JP2003061677A (ja) * 2001-08-28 2003-03-04 Olympus Optical Co Ltd 全身性エリテマトーデスの感受性遺伝子およびその使用
US20030119004A1 (en) * 2001-12-05 2003-06-26 Wenz H. Michael Methods for quantitating nucleic acids using coupled ligation and amplification
US7022476B2 (en) * 2002-02-26 2006-04-04 New York Society For Ruptured And Crippled Maintaining The Hospital For Special Surgery Human FcγRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof
CA2477611A1 (en) * 2002-03-01 2003-09-12 Ravgen, Inc. Rapid analysis of variations in a genome
US7811794B2 (en) 2003-03-18 2010-10-12 Celera Corporation Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
WO2005086872A2 (en) * 2004-03-10 2005-09-22 Celera, An Applera Corporation Business Ptpn22 polymorphisms in diagnosis and therapy
EP1863927A2 (en) * 2005-03-15 2007-12-12 Ares Trading S.A. Compositions and methods for treating and diagnosing inflammatory disorders
ATE549416T1 (de) 2005-08-05 2012-03-15 Genentech Inc Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten
US20070269827A1 (en) * 2006-05-18 2007-11-22 Oklahoma Medical Research Foundation Predicting and Diagnosing Patients With Autoimmune Disease
ES2661249T3 (es) * 2007-05-21 2018-03-28 Genentech, Inc. Métodos y composiciones para identificar y tratar el lupus
US20100099101A1 (en) * 2008-09-26 2010-04-22 Genentech, Inc. Methods for treating, diagnosing, and monitoring lupus

Similar Documents

Publication Publication Date Title
JP2010528590A5 (cg-RX-API-DMAC7.html)
JP2012503985A5 (cg-RX-API-DMAC7.html)
US10760123B2 (en) Sequential sequencing
Valencia et al. Assessment of target enrichment platforms using massively parallel sequencing for the mutation detection for congenital muscular dystrophy
JP2014533949A5 (cg-RX-API-DMAC7.html)
CN107475371B (zh) 发现药物基因组生物标志物的方法
JP2011512163A5 (cg-RX-API-DMAC7.html)
US20150159220A1 (en) Methods for predicting and detecting cancer risk
JP2013507127A5 (cg-RX-API-DMAC7.html)
CN103492588A (zh) 用于单体型测定的方法和系统
CN102203296A (zh) 年龄相关的黄斑变性中的遗传多态性
JP2022173308A (ja) エンザスタウリンの活性を予測するための方法および組成物
JP2011528903A5 (cg-RX-API-DMAC7.html)
RU2009147281A (ru) Способы и композиции для диагностики и лечения волчанки
RU2012118596A (ru) Способы лечения, диагностики и мониторинга волчанки
EP3350351A1 (en) Virome capture sequencing platform, methods of designing and constructing and methods of using
Fiorentino et al. Genetic variation in the miR‐708 gene and its binding targets in bipolar disorder
JP2008278779A (ja) 核酸ハイブリダイゼーション用溶液
JP2007526764A (ja) アルツハイマー病の発症年齢に関連するａｐｏｅ遺伝子マーカー
Wang et al. Development of a high-throughput resequencing array for the detection of pathogenic mutations in osteogenesis imperfecta
KR20230005816A (ko) 신경전달물질 수송체 억제제의 효능을 평가하기 위한 조성물 및 방법
US10519502B2 (en) Mitochondrial disease genetic diagnostics
Que et al. Genetic architecture modulates diet-induced hepatic mRNA and miRNA expression profiles in Diversity Outbred mice
EP3315613B1 (en) Methods and kits for diagnosing or assessing the risk of cervical cancer
US20180245140A1 (en) Kit and method for detecting single nucleotide polymorphism